These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10711914)

  • 1. A program for relapse prevention in schizophrenia: a controlled study.
    Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
    Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodromal symptoms of relapse in schizophrenic outpatients: retrospective and prospective study.
    Henmi Y
    Jpn J Psychiatry Neurol; 1993 Dec; 47(4):753-75. PubMed ID: 7911165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia.
    Gaebel W; Riesbeck M
    Schizophr Res; 2007 Sep; 95(1-3):19-29. PubMed ID: 17630253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study.
    Liu Y; Yang X; Gillespie A; Guo Z; Ma Y; Chen R; Li Z
    Psychiatry Res; 2019 Feb; 272():275-283. PubMed ID: 30594760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial.
    Komatsu H; Sekine Y; Okamura N; Kanahara N; Okita K; Matsubara S; Hirata T; Komiyama T; Watanabe H; Minabe Y; Iyo M
    Schizophr Res; 2013 Oct; 150(1):240-4. PubMed ID: 23998952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent vs maintenance medication in schizophrenia. Two-year results.
    Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
    Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection.
    Lee SH; Choi TK; Suh S; Kim YW; Kim B; Lee E; Yook KH
    Psychiatry Res; 2010 Feb; 175(3):195-9. PubMed ID: 20022120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
    Schooler NR; Keith SJ; Severe JB; Matthews SM; Bellack AS; Glick ID; Hargreaves WA; Kane JM; Ninan PT; Frances A; Jacobs M; Lieberman JA; Mance R; Simpson GM; Woerner MG
    Arch Gen Psychiatry; 1997 May; 54(5):453-63. PubMed ID: 9152099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.
    Ciudad A; San L; Bernardo M; Olivares JM; Polavieja P; Valladares A; Gilaberte I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):245-50. PubMed ID: 22056291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug.
    Chabannes JP; Bazin N; Leguay D; Nuss P; Peretti CS; Tatu P; Hameg A; Garay RP; Ferreri M
    Eur Psychiatry; 2008 Jan; 23(1):8-13. PubMed ID: 17964764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
    Spaniel F; Novak T; Bankovska Motlova L; Capkova J; Slovakova A; Trancik P; Matejka M; Höschl C
    J Psychiatr Ment Health Nurs; 2015 Dec; 22(10):811-20. PubMed ID: 26176646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia.
    Marder SR; Wirshing WC; Mintz J; McKenzie J; Johnston K; Eckman TA; Lebell M; Zimmerman K; Liberman RP
    Am J Psychiatry; 1996 Dec; 153(12):1585-92. PubMed ID: 8942455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
    Velligan DI; Bow-Thomas CC; Huntzinger C; Ritch J; Ledbetter N; Prihoda TJ; Miller AL
    Am J Psychiatry; 2000 Aug; 157(8):1317-23. PubMed ID: 10910797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA
    Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of a psycho-educational intervention for people diagnosed with schizophrenia and their primary caregivers in Jordan: a randomized controlled trial.
    Hasan AA; Callaghan P; Lymn JS
    BMC Psychiatry; 2015 Apr; 15():72. PubMed ID: 25885432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
    Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
    J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.